- A PT hike to $11 from $10 at Wunderlich Securities may be helping Symmetry Medical shares (SMA +2.8%) higher.
- Analyst James Terwilliger, which has a Buy rating on the name, believes 2014 revenue growth will be driven by a 6% boost in the Implant and Cases product lines.
- On the balance sheet side, Terwilliger postulates that "management will remain focused on reducing debt levels."
From other sites
After Hours Most Active for Nov 28, 2014 : CRC$, BAC, RYAM, KO, SMA, LBTYK, WFC, IFGL, INTC, MSFT, QQQ, AAPLat Nasdaq.com (Nov 28, 2014)
at Fox Business (Aug 11, 2014)
at MarketWatch.com (Aug 5, 2014)
at MarketWatch.com (Nov 10, 2010)
at CNBC.com (Jun 1, 2010)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs